Categories Earnings, Health Care

Venus Remedies Ltd Q4FY23 results out, revenue grows by over 10%

Venus Remedies Ltd is an Indian Pharmaceutical company with a presence in domestic and international markets. It is primarily engaged in the business of pharmaceutical products manufacturing. The company manufactures and sells a very wide range of pharmaceutical products in therapeutic segments like Anti-infective (antibiotics), oncology, neurology, pain management, skin & wound care, anti-microbial resistance, etc.

  • Venus Remedies Ltd reported Total revenue for Q4 FY23 of ₹156 Crore, up from ₹142 Crore year on year depicting a growth of 10%.
  • Total Expenses for Q4 FY23 of ₹131 Crore down, from ₹137 Crore year on year, a decline of 4%. 
  • Consolidated Net Profit of ₹11 Crore, up 100% from ₹0 Crore in the same quarter of the previous year.
  •  The Earnings per Share is ₹8.27, up 4,674% from ₹0.17 in the same quarter of the previous year.

Most Popular

Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript

Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah

All you need to know about Antony Waste Handling Cell in one article

Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?

Demystifying the Leading Non-Ferrous Recycling Company of India

“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,

Top